JamesKManganMDPhD
Hematology • La Jolla, CAHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Associate Clinical Professor of Medicine, University of California-San Diego
Dr. Mangan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 Health Sciences Drive, Mail Code 0960
Moores Cancer Center, University of California-San Diego
La Jolla, CA 92093Phone+1 858-822-6600Fax+1 858-822-6844- Is this information wrong?
Summary
- Clinical care of patients with acute leukemia, chronic myeloid leukemia, MDS, MPNs, and aplastic anemia and allogeneic stem cell transplant for those disorders.
Clinical research in novel therapies for acute leukemias and myelodysplastic syndromes.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2008 - 2011
University of Michigan Health SystemResidency, Internal Medicine, 2005 - 2008
Lewis Katz School of Medicine at Temple UniversityClass of 2005
Certifications & Licensure
CA State Medical License 2019 - 2025
PA State Medical License 2008 - 2021
MI State Medical License 2005 - 2011- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis Start of enrollment: 2014 Jul 16
- Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox) Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- IDH2-mutated near ETP-ALL with aggressive leukemia cutis and brisk response to venetoclax and decitabine.Vaidya, P., Wang, H., Don, M., Hinds, B., Mangan, J.> ;Leukemia Research Reports. 2024 Jan 1
- Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia.Ibrahim Aldoss, Parastou Tizro, Davsheen Bedi, James K Mangan, Mary C Clark, David Spencer, Joo Y Song, Sindhu Cherian, Raju Pillai, Young Kim, Nitin Mahajan, Ketevan ...> ;Haematologica. 2023 Dec 1
- 1 citationsClofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.Matthew P Connor, Alison W Loren, Elizabeth O Hexner, Mary Ellen Martin, Saar I Gill, Selina M Luger, James K Mangan, Alexander E Perl, Shannon R McCurdy, Keith W Prat...> ;Transplantation and Cellular Therapy. 2023 Feb 1
- Join now to see all
Journal Articles
- Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium Difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsEdward A Stadtmauer, James K Mangan, Elizabeth O Hexner, David L Porter, Daria V Babushok, Jacqueline Smith, Craig W Freyer, Mindy Schuster, Noelle V Frey, Selina M Lu..., Clinical Infectious Diseases
Press Mentions
Drug Revumenib Achieves Complete Cancer Remission in 18 People with LeukemiaMarch 21st, 2023
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Hospital Affiliations
- University of California San Diego Jacobs Medical CenterLa Jolla, California
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
